Trial Profile
Combination treatment of TACE [transcatheter arterial chemoembolisation] with recombinant human endosta[t]in administrated via hepatic artery in hepatocellular carcinoma.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Epirubicin; Ethiodized oil
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2007 New trial record.